Strategic footprint Executive Insight operates in Switzerland, the UK, and the US with a client base that includes six of the top ten global pharma companies, signaling strong cross-border engagement and potential for expanded regional services in North America and Europe.

Market Access strength The firm specializes in supporting biopharma product preparation, launch and commercialization, highlighting opportunities to upsell integrated market access, pricing and payer strategy offerings to current and prospective clients seeking end-to-end support.

Growth momentum With 60+ employees and a revenue range of $10M–$25M, there is room to scale services such as advisory, digital transformation, and data analytics capabilities to capture larger project scopes with existing pharma relationships.

Leadership depth Key personnel promotions and long-standing hires indicate a matured leadership and partner network (including named partners and directors), presenting entry points for senior-level engagements around strategic consulting, portfolio optimization, and US market entry initiatives.

Diversity advantage A diverse, inclusive team spanning 21 nationalities and a leadership team with 55% women provides a value proposition for multinational clients prioritizing DEI-driven approaches, offering opportunities to tailor ESG and evidence generation programs as differentiators.